Pharma News, 2019

KENILWORTH, N.

Boehringer Ingelheim has announced that its drug nintedanib, already sold under various brand names such as Ofev and Vargatef, has met its primary endpoint in the SENSCIS trial.

Cegedim has announced that it is set to engage in an innovative collaboration on Real World Data for healthcare improvement in Europe with Sanofi.

Artificial intelligence is better than specialist doctors at diagnosing lung cancer, a US study suggests.

Food gives us the nutrients we need to survive, and we know a balanced diet contributes to good health.

Management of people with heart failure in the UK has shortcomings in screening, continuity of care, and medication doses, which disproportionally impact women and older people, according to a study l...

New research supports the effectiveness and safety of esketamine nasal spray in treating depression in people who have not responded to previous treatment.

SYDNEY, May 17 (Xinhua) -- Asthma sufferers can breathe a little easier with a potential new treatment revealed on Friday, targeting the underlying cause of the disease rather than the symptom...

The global leader in Breath Biopsy for applications in early disease detection announced the collaboration to discover and validate a breath-based test to help facilitate the early diagnosis of pulmon...

AstraZeneca’s Novel START trial for its Symbicort Turbuhaler (budesonide/formoterol) demonstrated a reduction in the rate of asthma attacks in patients with mild asthma, compared to common t...

Roche (SIX.

Background.